section name header

Y-Site Injection Compatibility (1:1 Mixture)

Cisatracurium besylate

(Mfr: GW)(Conc: 5 mg/mLa)

I

Cefotaxime sodium

(Mfr: HO)(Conc: 20 mg/mLa)

Remarks:

Subvisible haze forms immediately

Ref:

2074